We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blocking Ephrin-A5 Spurs Recovery from Stroke in Mouse Model

By LabMedica International staff writers
Posted on 15 Aug 2012
Neuroscience researchers have identified a novel molecule in the brain that retards recovery from stroke by blocking the formation of new connections between neurons.

Investigators at the University of California, Los Angeles (USA) were attracted by the indication of increased production of the growth inhibitor ephrin-A5 by brain cells after stroke in a mouse model.

Ephrin-A5 is a protein encoded by a member of the ephrin gene family that prevents axon bundling in co-cultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. More...


Results published in the July 25, 2012, online edition of the journal Proceedings of the National Academy of Sciences of the USA (PNAS) revealed that damage to the brain induced ephrin-A5 production in reactive astrocytes where it acted as an inhibitor of axonal sprouting and motor recovery. Blocking ephrin-A5 signaling using a unique tissue delivery system induced the formation of a new pattern of axonal projections in motor, premotor, and prefrontal circuits and mediated recovery after stroke in the mice through these new projections. Combined blockade of ephrin-A5 and forced use of the affected limb promoted new and surprisingly widespread axonal projections within the entire cortical hemisphere on the same side of the body as the stroke.

If duplicated in humans, drugs to block ephrin-A5 activity could pave the way for a more rapid recovery from stroke and may allow a synergy with existing treatments, such as physical therapy.

Related Links:
University of California, Los Angeles




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.